ALDBT Fundamental Analysis - DBT

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to ALDBT. ALDBT was compared to 70 industry peers in the Electrical Equipment industry. The financial health of ALDBT is average, but there are quite some concerns on its profitability. ALDBT has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALDBT had negative earnings in the past year.

In the past year ALDBT has reported a negative cash flow from operations.

ALDBT had negative earnings in each of the past 5 years.

ALDBT had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of ALDBT (-14.55%) is worse than 87.14% of its industry peers.

ALDBT has a worse Return On Equity (-46.17%) than 82.86% of its industry peers.

		Industry Rank	Sector Rank
ROA	-14.55%
ROE	-46.17%
ROIC	N/A

ROA(3y)-23.64%

ROA(5y)-31.04%

ROE(3y)-53.43%

ROE(5y)-63.59%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALDBT has a worse Gross Margin (31.98%) than 62.86% of its industry peers.

In the last couple of years the Gross Margin of ALDBT has grown nicely.

ALDBT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	31.98%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y1.62%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALDBT does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ALDBT has been increased compared to 1 year ago.

The number of shares outstanding for ALDBT has been reduced compared to 5 years ago.

ALDBT has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -0.80, we must say that ALDBT is in the distress zone and has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -0.80, ALDBT is doing worse than 85.71% of the companies in the same industry.

ALDBT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-0.8

ROIC/WACCN/A

WACC3.85%

2.3 Liquidity

ALDBT has a Current Ratio of 0.67. This is a bad value and indicates that ALDBT is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 0.67, ALDBT is doing worse than 94.29% of the companies in the same industry.

ALDBT has a Quick Ratio of 0.67. This is a bad value and indicates that ALDBT is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 0.41, ALDBT is doing worse than 95.71% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	0.67
Quick Ratio	0.41

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALDBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 87.62%, which is quite impressive.

Looking at the last year, ALDBT shows a very negative growth in Revenue. The Revenue has decreased by -18.47% in the last year.

ALDBT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.98% yearly.

EPS 1Y (TTM)87.62%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%3.08%

Revenue 1Y (TTM)-18.47%

Revenue growth 3Y32.91%

Revenue growth 5Y1.98%

Sales Q2Q%-29.93%

3.2 Future

Based on estimates for the next years, ALDBT will show a very strong growth in Earnings Per Share. The EPS will grow by 24.42% on average per year.

ALDBT is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -90.45% yearly.

EPS Next Y28.13%

EPS Next 2Y20.08%

EPS Next 3Y24.42%

EPS Next 5YN/A

Revenue Next Year25.09%

Revenue Next 2Y25.88%

Revenue Next 3Y-90.45%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALDBT. In the last year negative earnings were reported.

Also next year ALDBT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

ALDBT's earnings are expected to grow with 24.42% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y20.08%

EPS Next 3Y24.42%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALDBT does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

DBT

EPA:ALDBT (1/6/2026, 7:00:00 PM)

0.0346

+0 (+0.29%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryElectrical Equipment

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0.23%

Inst Owner ChangeN/A

Ins Owners0.08%

Ins Owner ChangeN/A

Market Cap173.69K

Revenue(TTM)8.53M

Net Income(TTM)-4.62M

Analysts84.44

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.02
P/FCF	N/A
P/OCF	N/A
P/B	0.02
P/tB	0.03
EV/EBITDA	N/A

EPS(TTM)-0.71

EYN/A

EPS(NY)-3.86

Fwd EYN/A

FCF(TTM)-2.23

FCFYN/A

OCF(TTM)-1.4

OCFYN/A

SpS1.7

BVpS2

TBVpS1.36

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-14.55%
ROE	-46.17%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	31.98%
FCFM	N/A

ROA(3y)-23.64%

ROA(5y)-31.04%

ROE(3y)-53.43%

ROE(5y)-63.59%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y1.62%

F-Score3

Asset Turnover0.27

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	260.25%
Cap/Sales	48.8%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.67
Quick Ratio	0.41
Altman-Z	-0.8

F-Score3

WACC3.85%

ROIC/WACCN/A

Cap/Depr(3y)432.84%

Cap/Depr(5y)302.01%

Cap/Sales(3y)51.01%

Cap/Sales(5y)37.98%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)87.62%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%3.08%

EPS Next Y28.13%

EPS Next 2Y20.08%

EPS Next 3Y24.42%

EPS Next 5YN/A

Revenue 1Y (TTM)-18.47%

Revenue growth 3Y32.91%

Revenue growth 5Y1.98%

Sales Q2Q%-29.93%

Revenue Next Year25.09%

Revenue Next 2Y25.88%

Revenue Next 3Y-90.45%

Revenue Next 5YN/A

EBIT growth 1Y19.76%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year39.41%

EBIT Next 3Y26.01%

EBIT Next 5YN/A

FCF growth 1Y-16.03%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-39.36%

OCF growth 3YN/A

OCF growth 5YN/A

DBT / ALDBT.PA FAQ

Can you provide the ChartMill fundamental rating for DBT?

ChartMill assigns a fundamental rating of 2 / 10 to ALDBT.PA.

Can you provide the valuation status for DBT?

ChartMill assigns a valuation rating of 1 / 10 to DBT (ALDBT.PA). This can be considered as Overvalued.

What is the profitability of ALDBT stock?

DBT (ALDBT.PA) has a profitability rating of 1 / 10.

Is the dividend of DBT sustainable?

The dividend rating of DBT (ALDBT.PA) is 0 / 10 and the dividend payout ratio is 0%.

DBT (ALDBT.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

DBT / ALDBT.PA FAQ

Can you provide the ChartMill fundamental rating for DBT?

Can you provide the valuation status for DBT?

What is the profitability of ALDBT stock?

Is the dividend of DBT sustainable?